Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia

View ORCID ProfileAubin Moutal, View ORCID ProfileLaurent F. Martin, View ORCID ProfileLisa Boinon, View ORCID ProfileKimberly Gomez, View ORCID ProfileDongzhi Ran, Yuan Zhou, View ORCID ProfileHarrison J. Stratton, Song Cai, Shizhen Luo, Kerry Beth Gonzalez, View ORCID ProfileSamantha Perez-Miller, Amol Patwardhan, Mohab M. Ibrahim, View ORCID ProfileRajesh Khanna
doi: https://doi.org/10.1101/2020.07.17.209288
Aubin Moutal
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aubin Moutal
Laurent F. Martin
2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurent F. Martin
Lisa Boinon
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisa Boinon
Kimberly Gomez
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kimberly Gomez
Dongzhi Ran
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dongzhi Ran
Yuan Zhou
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harrison J. Stratton
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harrison J. Stratton
Song Cai
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shizhen Luo
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry Beth Gonzalez
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Perez-Miller
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samantha Perez-Miller
Amol Patwardhan
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
4Comprehensive Pain and Addiction Center, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohab M. Ibrahim
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
4Comprehensive Pain and Addiction Center, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rajesh Khanna
1Department of Pharmacology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
2Department of Anesthesiology, College of Medicine, The University of Arizona, Tucson, Arizona, 85724 United States of America
3Center for Innovation in Brain Sciences, University of Arizona, Tucson, Arizona 85721, United States of America
4Comprehensive Pain and Addiction Center, The University of Arizona, Tucson, Arizona, 85724 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rajesh Khanna
  • For correspondence: rkhanna@arizona.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

Global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues unabated. Binding of SARS-CoV-2’s Spike protein to host angiotensin converting enzyme 2 triggers viral entry, but other proteins may participate, including neuropilin-1 receptor (NRP-1). As both Spike protein and vascular endothelial growth factor-A (VEGF-A) – a pro-nociceptive and angiogenic factor, bind NRP-1, we tested if Spike could block VEGF-A/NRP-1 signaling. VEGF-A–triggered sensory neuronal firing was blocked by Spike protein and NRP-1 inhibitor EG00229. Pro-nociceptive behaviors of VEGF-A were similarly blocked via suppression of spontaneous spinal synaptic activity and reduction of electrogenic currents in sensory neurons. Remarkably, preventing VEGF-A/NRP-1 signaling was antiallodynic in a neuropathic pain model. A ‘silencing’ of pain via subversion of VEGF-A/NRP-1 signaling may underlie increased disease transmission in asymptomatic individuals.

Competing Interest Statement

R. Khanna is the co-founder of Regulonix LLC, a company developing non-opioids drugs for chronic pain. In addition, R. Khanna has patents US10287334 and US10441586 issued to Regulonix LLC. The other authors declare no competing financial interests.

Footnotes

  • 1. We clarified which Spike protein fragment we used throughout our experiments. We have removed references to the receptor binding domain (RBD) of Spike for clarity. 2. We added a new panel to Figure 1 (A) which replicates the binding between Spike and NRP-1. An interaction between Spike (S1 domain aa 16-685, containing the CendR motif 682RRAR685) and the extracellular portion of NRP-1 was confirmed by enzyme-linked immunosorbent assay (ELISA) (Fig. 1A). We calculated an equilibrium constant of dissociation (Kd) for this interaction to be ~166.2 nM (Fig. 1A). 3. We added new data panels (Fig. 6E, F) showing that Spike reverses mechanical allodynia in female rats with SNI.

  • ABBREVIATIONS USED

    ACE2
    Angiotensin converting enzyme 2
    AUC
    area under the curve
    CaV2.2
    N-type voltage-gated calcium channel
    COVID-19
    coronavirus disease 2019
    DRG
    dorsal root ganglia
    MEA
    multi-well microelectrode array
    NaV1.7
    voltage-gated sodium channel isoform 7
    NRP-1
    Neuropilin-1
    PWTs
    paw withdrawal thresholds
    SARS-CoV-2
    Severe acute respiratory syndrome coronavirus 2
    sEPSCs
    spontaneous excitatory postsynaptic currents
    SNI
    spared nerve injury
    VEGF-A
    vascular endothelial growth factor-A
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted September 14, 2020.
    Download PDF

    Supplementary Material

    Email

    Thank you for your interest in spreading the word about bioRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
    (Your Name) has forwarded a page to you from bioRxiv
    (Your Name) thought you would like to see this page from the bioRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
    Aubin Moutal, Laurent F. Martin, Lisa Boinon, Kimberly Gomez, Dongzhi Ran, Yuan Zhou, Harrison J. Stratton, Song Cai, Shizhen Luo, Kerry Beth Gonzalez, Samantha Perez-Miller, Amol Patwardhan, Mohab M. Ibrahim, Rajesh Khanna
    bioRxiv 2020.07.17.209288; doi: https://doi.org/10.1101/2020.07.17.209288
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia
    Aubin Moutal, Laurent F. Martin, Lisa Boinon, Kimberly Gomez, Dongzhi Ran, Yuan Zhou, Harrison J. Stratton, Song Cai, Shizhen Luo, Kerry Beth Gonzalez, Samantha Perez-Miller, Amol Patwardhan, Mohab M. Ibrahim, Rajesh Khanna
    bioRxiv 2020.07.17.209288; doi: https://doi.org/10.1101/2020.07.17.209288

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neuroscience
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (2548)
    • Biochemistry (4995)
    • Bioengineering (3503)
    • Bioinformatics (15291)
    • Biophysics (6934)
    • Cancer Biology (5432)
    • Cell Biology (7783)
    • Clinical Trials (138)
    • Developmental Biology (4564)
    • Ecology (7186)
    • Epidemiology (2059)
    • Evolutionary Biology (10264)
    • Genetics (7542)
    • Genomics (9835)
    • Immunology (4905)
    • Microbiology (13311)
    • Molecular Biology (5170)
    • Neuroscience (29607)
    • Paleontology (203)
    • Pathology (842)
    • Pharmacology and Toxicology (1471)
    • Physiology (2155)
    • Plant Biology (4788)
    • Scientific Communication and Education (1016)
    • Synthetic Biology (1343)
    • Systems Biology (4025)
    • Zoology (773)